Sujith Samarasinghe

13PUBLICATIONS
40CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 07, 2025
High-Dose Methotrexate in Children and Young Adults With ALL and Lymphoblastic Lymphoma: Results of the Randomized Phase III Study UKALL 2011.

Amy A Kirkwood, Nicholas Goulden, John Moppett

|Apr 15, 2024
Intention-to-treat outcomes utilising a stringent event definition in children and young people treated with tisagenlecleucel for r/r ALL through a national access scheme.

Macarena Oporto Espuelas, Saskia Burridge, Amy A Kirkwood

|Nov 15, 2023
Blinatumomab for First-Line Treatment of Children and Young Persons With B-ALL.

Angus Hodder, Avijeet K Mishra, Amir Enshaei

|Jun 17, 2022
Time to Cure for Childhood and Young Adult Acute Lymphoblastic Leukemia Is Independent of Early Risk Factors: Long-Term Follow-Up of the UKALL2003 Trial.

Anthony V Moorman, Grace Antony, Rachel Wade

|Apr 03, 2022
Identification of a c-MYB-directed therapeutic for acute myeloid leukemia.

Katherine Clesham, Vanessa Walf-Vorderwülbecke, Luca Gasparoli

|Sep 14, 2020
Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL-class fusion.

Anthony V Moorman, Claire Schwab, Emily Winterman

Pageof 3

Frequent Collaborators

4 joint publications

Anthony V Moorman

4 joint publications

Ajay Vora

4 joint publications

John Moppett

3 joint publications

Jack Bartram